KR102852714B1 - 구강 내 항-염증제로서 프로바이오틱스의 용도 - Google Patents

구강 내 항-염증제로서 프로바이오틱스의 용도

Info

Publication number
KR102852714B1
KR102852714B1 KR1020187023798A KR20187023798A KR102852714B1 KR 102852714 B1 KR102852714 B1 KR 102852714B1 KR 1020187023798 A KR1020187023798 A KR 1020187023798A KR 20187023798 A KR20187023798 A KR 20187023798A KR 102852714 B1 KR102852714 B1 KR 102852714B1
Authority
KR
South Korea
Prior art keywords
composition
lactobacillus
oral
cctcc
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020187023798A
Other languages
English (en)
Korean (ko)
Other versions
KR20180102655A (ko
Inventor
마르커스 루돌프 괴츠
커스틴 홈그렌
니클라스 라르손
베른트 피에비흐
윌리엄 웨이드
Original Assignee
시므라이즈 아게
프로비 에이비
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시므라이즈 아게, 프로비 에이비 filed Critical 시므라이즈 아게
Publication of KR20180102655A publication Critical patent/KR20180102655A/ko
Application granted granted Critical
Publication of KR102852714B1 publication Critical patent/KR102852714B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020187023798A 2016-01-19 2017-01-18 구강 내 항-염증제로서 프로바이오틱스의 용도 Active KR102852714B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16151975.6 2016-01-19
EP16151975 2016-01-19
PCT/EP2017/051005 WO2017125447A1 (en) 2016-01-19 2017-01-18 Probiotics for use as anti-inflammatory agents in the oral cavity

Publications (2)

Publication Number Publication Date
KR20180102655A KR20180102655A (ko) 2018-09-17
KR102852714B1 true KR102852714B1 (ko) 2025-08-29

Family

ID=55237502

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020187023798A Active KR102852714B1 (ko) 2016-01-19 2017-01-18 구강 내 항-염증제로서 프로바이오틱스의 용도

Country Status (8)

Country Link
US (1) US11020441B2 (enExample)
EP (1) EP3405205B1 (enExample)
JP (2) JP7065776B2 (enExample)
KR (1) KR102852714B1 (enExample)
CN (1) CN109069556B (enExample)
AU (1) AU2017209868B2 (enExample)
NZ (1) NZ744342A (enExample)
WO (1) WO2017125447A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017209868B2 (en) 2016-01-19 2023-08-03 Probi Ab Probiotics for use as anti-inflammatory agents in the oral cavity
EP3196318A1 (en) 2016-01-19 2017-07-26 Symrise AG Probiotics for altering the composition of oral biofilms
EP3351259A1 (en) 2017-01-18 2018-07-25 Symrise AG Probiotics for aggregation with disease-associated species in the oral cavity
PL3494805T3 (pl) 2017-12-08 2025-10-06 Chr. Hansen HMO GmbH Suszone rozpyłowo tetrasacharydy
ES3039971T3 (en) 2017-12-08 2025-10-28 Chr Hansen Hmo Gmbh Spray-dried 3-fucosyllactose
EP4733390A3 (en) * 2018-05-09 2026-07-15 Kobiolabs, Inc. Lactobacillus paracasei strain and use thereof
WO2020001747A1 (en) * 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
GB201908154D0 (en) * 2019-06-07 2019-07-24 Probi Ab Lactobacillus compositions and uses thereof
CN111904985B (zh) * 2020-09-15 2021-10-22 广东南芯医疗科技有限公司 副干酪乳杆菌L.p R3-10在制备预防或治疗口腔炎症性疾病药物中的应用
JP7884920B2 (ja) * 2021-06-30 2026-07-06 サンスター株式会社 乳酸菌含有組成物
CN113881751A (zh) * 2021-09-23 2022-01-04 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） 口腔菌液载体的应用
CN113832062B (zh) * 2021-09-27 2022-10-28 微康益生菌(苏州)股份有限公司 一种副干酪乳杆菌lc86及其在预防或治疗龋齿和牙周炎上的应用
CN113712841B (zh) * 2021-11-01 2022-02-11 深圳市萱嘉生物科技有限公司 一种甘油葡萄糖苷在制备口腔护理产品中的应用
JP7814921B2 (ja) * 2021-12-24 2026-02-17 サンスター株式会社 乳酸菌含有組成物
CN114606164B (zh) * 2022-04-08 2024-03-15 云南白药集团股份有限公司 一株副干酪乳杆菌Probio-01及其制备益生菌口腔制剂的用途
CN114796287A (zh) * 2022-06-09 2022-07-29 比菲德(北京)生物科技有限公司 一种可预防龋齿和清新口腔的益生菌粉及其应用
US20240091135A1 (en) * 2022-09-17 2024-03-21 Reshma N. Kheraj Compositions and methods for promoting oral health
CN116694525B (zh) * 2023-06-14 2024-08-06 南昌大学 一株植物乳杆菌及其在制备抑制或缓解或治疗口腔粘膜炎菌剂的应用
CN118141739B (zh) * 2024-03-08 2024-08-02 广州壹选日化科技有限公司 一种美白抗过敏牙膏的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008544753A (ja) * 2005-07-05 2008-12-11 プロビ エービー Ｆｅ、Ｚｎ、Ｃａから選択される金属およびこれらのイオンの吸収を増大させるための乳酸桿菌の使用

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518615A (en) 1983-08-23 1985-05-21 Warner-Lambert Company Non-adhesive chewing gum base composition
US4721620A (en) 1986-04-01 1988-01-26 Warner-Lambert Company Polyvinylacetate bubble gum base composition
US5093136A (en) 1991-05-08 1992-03-03 Nabisco Brands, Inc. Dual gum base bubble gum
US5266336A (en) 1991-11-12 1993-11-30 Wm. Wrigley Jr. Company High flavor impact non-tack chewing gum with reduced plasticization
US5601858A (en) 1994-12-29 1997-02-11 Warner-Lambert Company Non-stick chewing gum
IT1306716B1 (it) 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
US6986709B2 (en) 2001-09-21 2006-01-17 Igt Gaming device having games with variable game functions
US20040101495A1 (en) 2002-11-27 2004-05-27 Leena Nase Method for improving dental health
US20050281756A1 (en) * 2004-06-14 2005-12-22 Eamonn Connolly Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation
EP1634948A1 (en) 2004-09-10 2006-03-15 Basf Aktiengesellschaft Means and methods for preventing and/or treating caries
SE528382C2 (sv) * 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
EP1934328A1 (en) 2005-09-19 2008-06-25 Basf Se Microorganisms inhibiting the formation of foot malodor
KR101300086B1 (ko) * 2005-10-06 2013-08-30 프로비 아베 자가면역질환의 치료를 위한 락토바실러스의 용도
EP2046352A4 (en) 2006-06-06 2012-03-21 Univ Mcgill Fermented milk product and use thereof
CN101190239B (zh) 2006-11-28 2010-11-03 景岳生物科技股份有限公司 含有类干酪乳杆菌的产品
WO2008074473A2 (en) 2006-12-19 2008-06-26 Basf Se Uses and methods for preventing and/or treating caries caused by mutants streptococci
RU2009133376A (ru) 2007-03-27 2011-05-10 Дзе Проктер Энд Гэмбл Компани (US) Способы и наборы для введения пробиотиков
CN102123604A (zh) 2008-06-24 2011-07-13 Wm.雷格利Jr.公司 益生菌口香糖的制造方法
WO2010064373A1 (ja) 2008-12-04 2010-06-10 国立大学法人広島大学 Ｉｌ－８阻害剤およびその製造方法
JP2012512171A (ja) 2008-12-16 2012-05-31 ネステク ソシエテ アノニム 改善された口腔健康のための組成物及び方法
ES2778836T3 (es) * 2009-03-05 2020-08-12 Probiotical Spa Cepas de bacterias que tienen una alta actividad antiinflamatoria
DK2455095T3 (en) 2009-07-16 2017-07-24 Univ Hiroshima PROPHYLACTIC, IMPROVING OR THERAPEUTIC AGENT FOR ORAL DISEASES
DE202009011370U1 (de) 2009-08-21 2009-11-19 Dreyer Gmbh Vorrichtung zur Oberflächenbehandlung einer sich bewegenden Kunststoffschicht
DE202009011379U1 (de) 2009-08-24 2010-12-30 Khalifa, Samir Orale Präparate zur Mund- und Zahnpflege und Bekämpfung von Mundgeruch
CN101715908A (zh) 2009-12-11 2010-06-02 江南大学 一种提高益生菌清除微囊藻毒素效率的方法
CN101703179A (zh) 2009-12-11 2010-05-12 江南大学 一种清除食品中微囊藻毒素的方法
DK2364712T3 (da) 2010-03-11 2013-05-21 Kloarys Invest Ltd Topisk, kosmetisk eller farmaceutisk sammensætning, der omfatter probiotiske Lactobacillus-stammer, og anvendelse heraf
EP2420580A1 (en) * 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health
TWI572354B (zh) 2010-09-09 2017-03-01 明治股份有限公司 抑制發炎之組成物
US9308227B2 (en) * 2011-05-16 2016-04-12 Organobalance Medical Ag Lactic acid bacteria and compositions containing them against bacterial colds
JP5904028B2 (ja) 2012-06-19 2016-04-13 ライオン株式会社 乳酸菌及びその培養由来物、ならびにこれらを含有する組成物
CA2783414A1 (en) 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition
RU2492851C1 (ru) 2012-08-02 2013-09-20 Сергей Владимирович Кузнецов Способ профилактики и лечения воспаления в ротовой полости после стоматологической хирургической операции
EP2968422A1 (en) 2013-03-14 2016-01-20 Nestec S.A. Lactobacillus plantarum ncc 2936 preparations and oral health
US9587284B2 (en) 2014-02-21 2017-03-07 Asian Probiotics and Prebiotics Ltd. Lactic acid bacterium having immunomodulatory and anti-allergic effects and pharmaceutical composition containing the same
TWI505832B (zh) 2014-02-21 2015-11-01 Genmont Biotech Inc 乳酸菌、其組合物與彼等於治療自體免疫疾病暨其倂發症之用途
US9399048B2 (en) 2014-03-05 2016-07-26 Asian Probiotics And Prebiotics Ltd Lactic acid bacteria and its applications in immunomodulation and anti-inflammation
KR101825667B1 (ko) 2014-09-30 2018-02-06 주식회사 알엔에이 비배당체가 세포내에 축적되어 있는 미생물 제제의 제조방법 및 이에 의해 제조된 미생물 제제
JP2018532696A (ja) 2015-08-25 2018-11-08 カレイド・バイオサイエンシズ・インコーポレイテッド グリカン組成物およびその使用
AU2017209868B2 (en) 2016-01-19 2023-08-03 Probi Ab Probiotics for use as anti-inflammatory agents in the oral cavity
EP3196318A1 (en) 2016-01-19 2017-07-26 Symrise AG Probiotics for altering the composition of oral biofilms
GB201600975D0 (en) * 2016-01-19 2016-03-02 Probi Ab Novel strain of probiotic bacteria and compositions and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008544753A (ja) * 2005-07-05 2008-12-11 プロビ エービー Ｆｅ、Ｚｎ、Ｃａから選択される金属およびこれらのイオンの吸収を増大させるための乳酸桿菌の使用

Also Published As

Publication number Publication date
EP3405205B1 (en) 2020-07-15
NZ744342A (en) 2022-11-25
KR20180102655A (ko) 2018-09-17
JP7313418B2 (ja) 2023-07-24
JP2022031608A (ja) 2022-02-21
EP3405205A1 (en) 2018-11-28
WO2017125447A1 (en) 2017-07-27
JP7065776B2 (ja) 2022-05-12
AU2017209868A1 (en) 2018-08-02
BR112018014545A2 (pt) 2018-12-11
US11020441B2 (en) 2021-06-01
CN109069556A (zh) 2018-12-21
US20190388485A1 (en) 2019-12-26
JP2019502737A (ja) 2019-01-31
HK1259171A1 (en) 2019-11-29
CN109069556B (zh) 2022-11-25
AU2017209868B2 (en) 2023-08-03

Similar Documents

Publication Publication Date Title
JP7313418B2 (ja) 口腔内の抗炎症剤として用いるためのプロバイオティクス
CN108738308B (zh) 新颖的胚芽乳杆菌益生菌菌株和其组合物及其在炎症治疗中的用途
EP3405563B1 (en) Probiotics for altering the composition of oral biofilms
AU775452B2 (en) Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
EP3351259A1 (en) Probiotics for aggregation with disease-associated species in the oral cavity
HK1259171B (en) Probiotics for use as anti-inflammatory agents in the oral cavity
BR122025003123A2 (pt) Uso de lactobacillus plantarum como agente anti-inflamatório na cavidade oral, composição farmacêutica oral, produto de higiene oral, produto para nutrição e prazer compreendendo o referido microrganismo
BR122025002169A2 (pt) Uso de lactobacillus paracasei como agente anti-inflamatório na cavidade oral
BR112018014545B1 (pt) Uso de lactobacillus delbrueckii subsp. lactis como agente antiinflamatório na cavidade oral, composição farmacêutica oral, produto de higiene oral, produto para nutrição e prazer compreendendo o mesmo
BR122025002169B1 (pt) Uso de lactobacillus paracasei como agente anti-inflamatório na cavidade oral
BR122022006942B1 (pt) Composições compreendendo lactobacillus plantarum
HK40000927B (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
HK1259176B (en) Probiotics for altering the composition of oral biofilms

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

F11 Ip right granted following substantive examination

Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE)

PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

U12 Designation fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

Q13 Ip right document published

Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE)